Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

Open Access 01-12-2020 | Central Venous Catheter | Research

Central venous catheter-related bloodstream infection and colonization: the impact of insertion site and distribution of multidrug-resistant pathogens

Authors: Vassiliki Pitiriga, Petros Kanellopoulos, Ioannis Bakalis, Elsa Kampos, Ioannis Sagris, George Saroglou, Athanasios Tsakris

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

Background

Placement of central-venous catheters (CVCs) is an essential practice in the management of hospitalized patients, however, insertion at the commonly used sites has often the potential of inducing major complications. Neverthelss, the impact of specific site central line catheter insertion on catheter-associated bloodstream infections (CLABSIs) has not been clarified yet in the literature.

Objective

The aim of the study was to compare CLABSIs and catheter colonization rates among the three catheter insertion sites: subclavian (SC), internal jugular (IJ) and femoral (FEM) in hospitalized patients. Moreover, to analyze the distribution of pathogens and their antimicrobial resistance profiles at these three sites, concurrently.

Methods

We performed a retrospective analysis of data collected prospectively from all catheterized patients at a tertiary care Greek hospital from May 2016 to May 2018. Data was collected on 1414 CVCs and 13,054 CVC-days.

Results

Τhe incidence of CLABSIs among the three sites was as follows: SC:5.1/1000 catheter/days, IJ: 3.73/1000 catheter/days and FEM: 6.93/1000 catheter/days (p = 0.37). The incidence of colonization was as follows: SC:13.39/1000 catheter/days; IJ:7.34/ 1000 catheter/days; FEM:22.91/1000 catheter/days (p = 0.009). MDROs predominated in both CLABSIs and tip colonizations (59.3 and 61%, respectively) with Acinetobacter baumanii being the predominant pathogen (16/59, 27.1% and 44/144, 30.5%, respectively). The incidence of CLABSIs due to multidrug-resistant organisms (MDROs) was as follows: SC:3.83/1000 catheter days; IJ:1.49/1000 catheter days; FEM:5.86/1000 catheter days (p = 0.04). The incidence of tip colonization by MDROs among the 3 sites was as follows: SC:8.93/1000 catheter/days; IJ:4.48/1000 catheter/days; FEM:12.79/1000 catheter/days (p = 0.06). There was no significant difference in the type of pathogen isolated among site groups for both CLABSIs and tip colonizations.

Conclusions

FEM site of catheter insertion was associated with a higher rate of bloodstream infection and catheters’ colonization compared to IJ and SC sites. Furthermore, this survey highlights the changing trend of the distribution of frequent pathogens and resistance patterns towards MDR Gram-negative pathogens, underscoring the need for consistent monitoring of antimicrobial resistance patterns of these specific infections.
Literature
1.
go back to reference Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. Am J Infect Control. 2012;40:227–32.CrossRef Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. Am J Infect Control. 2012;40:227–32.CrossRef
2.
go back to reference Hollenbeak CS. The cost of catheter-related bloodstream infections: implications for the value of prevention. J Infus Nurs. 2011;34(5):309–13.CrossRef Hollenbeak CS. The cost of catheter-related bloodstream infections: implications for the value of prevention. J Infus Nurs. 2011;34(5):309–13.CrossRef
3.
go back to reference O'Grady NP, Alexander M, Dellinger EP, Burns LA, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Atlanta: Centers for Disease Control and Prevention; 2011. O'Grady NP, Alexander M, Dellinger EP, Burns LA, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Atlanta: Centers for Disease Control and Prevention; 2011.
4.
go back to reference Lutwick L, Al-Maani AS, Mehtar S, Memish Z, Rosenthal VD, Dramowski A, Lui G, Osman T, Bulabula A, Bearman G. Managing and preventing vascular catheter infections: a position paper of the international society for infectious diseases. Int J Infect Dis. 2019;84:22–9.CrossRef Lutwick L, Al-Maani AS, Mehtar S, Memish Z, Rosenthal VD, Dramowski A, Lui G, Osman T, Bulabula A, Bearman G. Managing and preventing vascular catheter infections: a position paper of the international society for infectious diseases. Int J Infect Dis. 2019;84:22–9.CrossRef
5.
go back to reference Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with FEM venous catheters as compared to SC and IJ venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012;40(8):2479–85.CrossRef Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with FEM venous catheters as compared to SC and IJ venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012;40(8):2479–85.CrossRef
6.
go back to reference Lorente L, Jimenez A, Iribarren JL, Jimenez JJ, Martin MM, Mora ML. The micro-organism responsible for central venous catheter related bloodstream infection depends on catheter site. Intensive Care Med. 2006;32:1449–50.CrossRef Lorente L, Jimenez A, Iribarren JL, Jimenez JJ, Martin MM, Mora ML. The micro-organism responsible for central venous catheter related bloodstream infection depends on catheter site. Intensive Care Med. 2006;32:1449–50.CrossRef
7.
go back to reference Ling ML, Apisarnthanarak A, Jaggi N, Harrington G, Morikane K, Thu LTA, et al. APSIC guide for prevention of central line associated bloodstream infections (CLABSI). Antimicrob Resist Infect Control. 2016;5:16.CrossRef Ling ML, Apisarnthanarak A, Jaggi N, Harrington G, Morikane K, Thu LTA, et al. APSIC guide for prevention of central line associated bloodstream infections (CLABSI). Antimicrob Resist Infect Control. 2016;5:16.CrossRef
8.
go back to reference Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. New Engl J Med. 1977;296:1305–9.CrossRef Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. New Engl J Med. 1977;296:1305–9.CrossRef
9.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRef Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRef
10.
go back to reference Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, Pettis AM, Rupp E, Sandora T, Maragakis LL, Yokoe DS. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(2):89–107. Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, Pettis AM, Rupp E, Sandora T, Maragakis LL, Yokoe DS. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(2):89–107.
11.
go back to reference Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA. Meta-analysis of SC insertion and non tunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med. 2012;40:1627–34.CrossRef Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA. Meta-analysis of SC insertion and non tunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med. 2012;40:1627–34.CrossRef
12.
go back to reference Reyes JA, Habash ML, Taylor RP. FEM central venous catheters are not associated with higher rates of infection in the pediatric critical care population. Am J Infect Control. 2012;40(1):43–7.CrossRef Reyes JA, Habash ML, Taylor RP. FEM central venous catheters are not associated with higher rates of infection in the pediatric critical care population. Am J Infect Control. 2012;40(1):43–7.CrossRef
13.
go back to reference Arvaniti K, Lathyris D, Blot S, Apostolidou-Kiouti F, Koulenti D, Haidich AB. Cumulative evidence of randomized controlled and observational studies on catheter-related infection risk of central venous catheter insertion site in ICU patients: a pairwise and network meta-analysis. Crit Care Med. 2017;45(4):e437–48.CrossRef Arvaniti K, Lathyris D, Blot S, Apostolidou-Kiouti F, Koulenti D, Haidich AB. Cumulative evidence of randomized controlled and observational studies on catheter-related infection risk of central venous catheter insertion site in ICU patients: a pairwise and network meta-analysis. Crit Care Med. 2017;45(4):e437–48.CrossRef
14.
go back to reference Van der Kooi TI, Wille JC, van Benthem BH. Catheter application, insertion vein and length of ICU stay prior to insertion affect the risk of catheter-related bloodstream infection. J Hosp Infect. 2012;80(3):238–44.CrossRef Van der Kooi TI, Wille JC, van Benthem BH. Catheter application, insertion vein and length of ICU stay prior to insertion affect the risk of catheter-related bloodstream infection. J Hosp Infect. 2012;80(3):238–44.CrossRef
15.
go back to reference Parienti JJ, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373(13):1220–9.CrossRef Parienti JJ, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373(13):1220–9.CrossRef
16.
go back to reference Wolf HH, Leithäuser M, Maschmeyer G, Salwender H, Klein U, Chaberny I, et al. Infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO): central venous catheter-related infections in hematology and oncology: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2008;87:863–76.CrossRef Wolf HH, Leithäuser M, Maschmeyer G, Salwender H, Klein U, Chaberny I, et al. Infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO): central venous catheter-related infections in hematology and oncology: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2008;87:863–76.CrossRef
19.
go back to reference The Joint Commission. Preventing central line–associated bloodstream infections: a global challenge, a global perspective. Oak Brook: Joint Commission Resources; 2012. The Joint Commission. Preventing central line–associated bloodstream infections: a global challenge, a global perspective. Oak Brook: Joint Commission Resources; 2012.
20.
go back to reference See I, Freifeld AG, Magill SS. Causative organisms and associated antimicrobial resistance in healthcare-associated central line-associated bloodstream infections from oncology settings, 2009–2012. Clin Infect Dis. 2016;62(10):1203–9.CrossRef See I, Freifeld AG, Magill SS. Causative organisms and associated antimicrobial resistance in healthcare-associated central line-associated bloodstream infections from oncology settings, 2009–2012. Clin Infect Dis. 2016;62(10):1203–9.CrossRef
21.
go back to reference Wright MO, Decker SG, Allen-Bridson K, Hebden JN, Leaptrot D. Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration: location mapping. Am J Infect Control. 2018;46(5):577–8.CrossRef Wright MO, Decker SG, Allen-Bridson K, Hebden JN, Leaptrot D. Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration: location mapping. Am J Infect Control. 2018;46(5):577–8.CrossRef
22.
go back to reference Marcos M, Soriano A, Iñurrieta A, Martínez JA, Romero A, Cobos N, et al. Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of gram-negative pathogens. J Antimicrob Chemother. 2011;66:2119–25.CrossRef Marcos M, Soriano A, Iñurrieta A, Martínez JA, Romero A, Cobos N, et al. Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of gram-negative pathogens. J Antimicrob Chemother. 2011;66:2119–25.CrossRef
23.
go back to reference Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, Edwards JR, Sievert DM. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–301.CrossRef Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, Edwards JR, Sievert DM. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–301.CrossRef
24.
go back to reference Lin KY, Cheng A, Chang YC, Hung MC, Wang JT, Sheng WH, et al. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care. J Microbiol Immunol Infect. 2017;50:339–48.CrossRef Lin KY, Cheng A, Chang YC, Hung MC, Wang JT, Sheng WH, et al. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care. J Microbiol Immunol Infect. 2017;50:339–48.CrossRef
25.
go back to reference Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, et al. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Crit Care Med. 2012;40(2):420–9.CrossRef Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, et al. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Crit Care Med. 2012;40(2):420–9.CrossRef
Metadata
Title
Central venous catheter-related bloodstream infection and colonization: the impact of insertion site and distribution of multidrug-resistant pathogens
Authors
Vassiliki Pitiriga
Petros Kanellopoulos
Ioannis Bakalis
Elsa Kampos
Ioannis Sagris
George Saroglou
Athanasios Tsakris
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-020-00851-1

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.